Champions Oncology(CSBR) - 2024 Q4 - Annual Results
Exhibit 99.1 NEWS One University Plaza, Suite 307 Hackensack, NJ 07601 Champions Oncology Reports Quarterly Revenue of 50.2 Million Hackensack, NJ – July 18, 2024 – Champions Oncology, Inc. (Nasdaq: CSBR), a leader in the development of advanced preclinical oncology solutions, today announced its financial results for the fiscal year and fourth quarter ended April 30, 2024. Fourth Quarter Financial Highlights: Fiscal Year 2024 Financial Highlights: Ronnie Morris, CEO of Cham ...